On March 10, 2021 CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, reported that it will present a poster at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting, to be held in a virtual format from April 10 to 15 and May 17 to 21, 2021 (Press release, CRISPR Therapeutics, MAR 10, 2021, View Source [SID1234576404]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Title: CD70 knockout: A novel approach to augment CAR-T cell function
Session Title: Adoptive Cell Therapy
Session Category: Immunology
Abstract Number: 1537, e-poster
Date and Time: Saturday, April 10, 2021, 8:30 a.m. ET via the AACR (Free AACR Whitepaper) website, www.aacr.org